Pharmaceuticals, Biotechnology and Life Sciences
ROCKVILLE, Md. and SUZHOU, China, Nov. 03, 2025 (GLOBE NEWSWIRE) — Ascentage Pharma Group International Inc. (NASDAQ: AAPG; HKEX: 6855),…
Reference is made to the private placement (the “Private Placement”) and the retail offering through PrimaryBid (the “PrimaryBid Offering”) announced by…
SAN DIEGO, Nov. 03, 2025 (GLOBE NEWSWIRE) — Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on…
Successful private placement and retail offering – Zelluna ASA raises NOK 58 million to advance the world’s first “off-the-shelf” TCR-NK…
— HUTCHMED unveils its innovative ATTC platform, potentially providing precision oncology with synergistic dual-mechanism of action — — Lead candidate…
Investor webcast to be held on Monday November 3, 2025 at 8:00 am ESTHAYWARD, Calif., Nov. 02, 2025 (GLOBE NEWSWIRE)…
REYKJAVIK, Iceland, Nov. 02, 2025 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and…
REYKJAVIK, ICELAND (November 2, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar…
MHRA response is based on the Phase 3 DRAGON interim analysis results Topline final data expected in Q4 2025 SAN DIEGO,…
COPENHAGEN, Denmark, November 1, 2025 – Bavarian Nordic A/S hereby issues the following clarification regarding the Health Emergency Preparedness and…